Corcept Therapeutics Incorporated CORT
CORT
Corcept Therapeutics Incorporated CRNX
Crinetics Pharmaceuticals, Inc. ENTA
Enanta Pharmaceuticals, Inc. FOLD
Amicus Therapeutics, Inc. CNTB
Connect Biopharma Holdings Limited CYTK
Cytokinetics, Incorporated SUPN
Supernus Pharmaceuticals, Inc. VNDA
Vanda Pharmaceuticals Inc. INVA
Innoviva, Inc.
Corcept Therapeutics Incorporated CRNX
Crinetics Pharmaceuticals, Inc. ENTA
Enanta Pharmaceuticals, Inc. FOLD
Amicus Therapeutics, Inc. CNTB
Connect Biopharma Holdings Limited CYTK
Cytokinetics, Incorporated SUPN
Supernus Pharmaceuticals, Inc. VNDA
Vanda Pharmaceuticals Inc. INVA
Innoviva, Inc.
Performance
| Periode | CORT | CRNX | ENTA | FOLD | CNTB | CYTK | SUPN | VNDA | INVA |
|---|---|---|---|---|---|---|---|---|---|
| 6M | 7.78 % | 54.35 % | 134.97 % | 28.09 % | 197.60 % | 55.34 % | 54.72 % | 28.57 % | -0.97 % |
| YTD | 48.01 % | -12.84 % | 97.14 % | -10.85 % | 53.72 % | 22.71 % | 34.50 % | 10.17 % | -0.29 % |
| 1Y | 63.27 % | -15.39 % | -2.56 % | -20.35 % | 32.86 % | 10.17 % | 48.85 % | 10.40 % | -12.77 % |
| 3Y | 179.09 % | 151.71 % | -77.13 % | -22.28 % | 95.17 % | 25.19 % | 57.61 % | -45.31 % | 33.98 % |
| 5Y | 305.04 % | 177.86 % | -75.93 % | -47.20 % | -89.94 % | 283.64 % | 131.90 % | -52.50 % | 63.37 % |
| 10Y | 1 872.27 % | 83.31 % | -70.96 % | 12.16 % | -89.94 % | 766.38 % | 235.39 % | -50.83 % | 108.03 % |
| From the beginning | 504.74 % | 83.31 % | -35.86 % | -42.48 % | -89.94 % | -37.85 % | 812.48 % | -45.14 % | 27.92 % |